PT - JOURNAL ARTICLE AU - Arundhati Bakshi AU - Alicia Van Doren AU - Colette Maser AU - Kathleen Aubin AU - Collette Stewart AU - Shannon Soileau AU - Kate Friedman AU - Alexis Williams TI - Identifying Louisiana communities at the crossroads of environmental and social vulnerability, COVID-19, and asthma AID - 10.1101/2021.07.19.21257742 DP - 2021 Jan 01 TA - medRxiv PG - 2021.07.19.21257742 4099 - http://medrxiv.org/content/early/2021/11/15/2021.07.19.21257742.short 4100 - http://medrxiv.org/content/early/2021/11/15/2021.07.19.21257742.full AB - The COVID-19 pandemic has disproportionately affected the socially and environmentally vulnerable, including through indirect effects on other health conditions. Asthma is one such condition, which may be exacerbated by both prolonged adverse in-home exposures if quarantining in unhealthy homes and prolonged outdoor exposures if the ambient air quality is unhealthy or hazardous. As both are often the case in Environmental Justice (EJ) communities, here we have analyzed data at the census tract (CT) level for Louisiana to assess any correlation between social and environmental vulnerability, and health issues like COVID-19 and asthma. Higher Social Vulnerability Index (SVI), Particulate Matter less than 2.5 µm in diameter (PM2.5) and Ozone levels were associated with higher rates of cumulative COVID-19 incidence at various time points during the pandemic, as well as higher average annual asthma hospitalization rates and estimated asthma prevalence. Further, cumulative COVID-19 incidence during the first three months of the pandemic was moderately correlated with both asthma hospitalizations and estimated prevalence, suggesting similar underlying factors may be affecting both conditions. Additionally, 137 CTs were identified where social and environmental vulnerabilities co-existed, of which 75 (55%) had high estimated prevalence of asthma. These areas are likely to benefit from asthma outreach that considers both social and environmental risk factors. Fifteen out of the 137 CTs (11%) not only had higher estimated prevalence of asthma but also a high burden of COVID-19. Further research in these areas may help to elucidate any common social determinants of health that underlie both asthma and COVID-19 burdens, as well as better clarify the possible role of the environment as related to the COVID-19 burden in Louisiana.Competing Interest StatementThe authors have declared no competing interest.Funding StatementAuthors in this study have been supported through the CDC Environmental Public Health Tracking Cooperative Agreement (AB, KF, AW); the EPA State Environmental Justice Cooperative Agreement (AB); and the State General Fund (CM, CS, SS, KA). Funders have had no role in the study design or execution.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Louisiana Department of Health (LDH) IRB has determined that this protocol meets the criteria under 45 CFR 46.104(d)(4) as EXEMPT from review and not requiring consent. HIPAA regulations for use of research data may still apply and all reportable information should meet HIPAA criteria for de-identification under section 164.514 of the HIPAA law.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSocial Vulnerability, Environmental and COVID-19 data are publicly available, and links are provided in the manuscript. The Asthma and Indoor Environmental Quality data cannot be posted publicly due to HIPAA restrictions, but can be made available by LDH upon request (tracking{at}la.gov), following appropriate suppressions and IRB reviews as necessary.